» Articles » PMID: 25092292

MiR-15b/16-2 Regulates Factors That Promote P53 Phosphorylation and Augments the DNA Damage Response Following Radiation in the Lung

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2014 Aug 6
PMID 25092292
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are regulatory RNAs frequently dysregulated in disease and following cellular stress. Investigators have described changes in miR-15b expression following exposure to several stress-inducing anticancer agents, including ionizing radiation (IR), etoposide, and hydrogen peroxide. However, the role for miR-15b as a mediator of cellular injury in organs such as the lung has yet to be explored. In this study, we examined miR-15b expression patterns as well as its potential role in DNA damage and repair in the setting of IR exposure. We showed that miR-15b is up-regulated in a dose- and time-dependent manner in human bronchial epithelial cells following IR. miR-15b expression was highest after 2 h of IR and decreased gradually. Survival rates following IR were also higher in miR-15b/16-2-overexpressing cells. Cell cycle arrest in G2/M phase and an increased DNA repair response were observed in IR-exposed miR-15b/16-2 stable cells. We observed an up-regulation of components of the ataxia telangiectasia mutated (ATM)/Chek1/p53 pathway in miR-15b/16-2-overexpressing cells after IR. Moreover, a pathway-based PCR expression array of genes demonstrated that miR-15b/16-2 overexpression significantly induced the expression of genes involved in ATM/ataxia telangiectasia and Rad-3-related (ATR) signaling, apoptosis, the cell cycle, and DNA repair pathways. Here we demonstrated a novel biological link between miR-15b and DNA damage and cellular protection in lung cells. We identified Wip1 (PPM1D) as a functional target for miR-15b and determined that miR-15b induction of the DNA damage response is partially dependent upon suppression of Wip1. Our study suggests that miR-15b/Wip1 could be a potential therapeutic target in radiation-induced lung disease.

Citing Articles

Differential miRNA expression of hypoxic MCF7 and PANC-1 cells.

Al-Sisan S, Zihlif M, Hammad H Front Endocrinol (Lausanne). 2023; 14:1110743.

PMID: 37583428 PMC: 10424510. DOI: 10.3389/fendo.2023.1110743.


Suppressive effects of umbilical cord mesenchymal stem cell-derived exosomal miR-15a-5p on the progression of cholangiocarcinoma by inhibiting CHEK1 expression.

Li N, Wang B Cell Death Discov. 2022; 8(1):205.

PMID: 35428780 PMC: 9012823. DOI: 10.1038/s41420-022-00932-7.


Precision radiotherapy for non-small cell lung cancer.

Yang W, Hsu F, Yang P J Biomed Sci. 2020; 27(1):82.

PMID: 32693792 PMC: 7374898. DOI: 10.1186/s12929-020-00676-5.


6mer Seed Toxicity in Viral microRNAs.

Murmann A, Bartom E, Schipma M, Vilker J, Chen S, Peter M iScience. 2019; 23(2):100737.

PMID: 31838022 PMC: 7033618. DOI: 10.1016/j.isci.2019.11.031.


Construction of prognostic microRNA signature for human invasive breast cancer by integrated analysis.

Shi W, Dong F, Jiang Y, Lu L, Wang C, Tan J Onco Targets Ther. 2019; 12:1979-2010.

PMID: 30936717 PMC: 6430069. DOI: 10.2147/OTT.S189265.


References
1.
Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

2.
Lu Y, Chen Y, Wang H, Tsai C, Chen W, Huang Y . Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res (Phila). 2012; 5(4):665-74. DOI: 10.1158/1940-6207.CAPR-11-0358. View

3.
Sugawara K, Mizumoto M, Numajiri H, Ohno T, Ohnishi K, Ishikawa H . Proton beam therapy for a patient with a giant thymic carcinoid tumor and severe superior vena cava syndrome. Rare Tumors. 2014; 6(2):5177. PMC: 4083663. DOI: 10.4081/rt.2014.5177. View

4.
McCabe N, Turner N, Lord C, Kluzek K, Bialkowska A, Swift S . Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res. 2006; 66(16):8109-15. DOI: 10.1158/0008-5472.CAN-06-0140. View

5.
Ouyang W, Su S, Hu Y, Lu B, Ma Z, Li Q . Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: reanalysis of the findings of a single-center prospective study. BMC Cancer. 2014; 14:491. PMC: 4227092. DOI: 10.1186/1471-2407-14-491. View